A recent study showed that oral administration of soluble yeast β-glucan inhibited inflammatory gene expression in visceral adipose tissue (VAT), improved the gut microbiota, and reduced inflammation in the intestine of the leptin mutant mice (ob/ob mice), which develop obesity and diabetes, similar to individuals with type-II diabetes42. Here, LEP is linked to obesity disorder.